Reduction of Motor Disorder in 6-OHDA-Induced Severe Parkinsonism Rats by Post Treatment with Granulocyte-Colony Stimulating Factor

Chia-Hsin Liao ； Shin-Yuan Chen ； Jon-Son Kuo ； Cheng-Yoong Pang

《The Chinese Journal of Physiology》 56卷3期 (2013/06) Pp. 147-154

https://doi.org/10.4077/CJP.2013.BAB125

並列摘要

Granulocyte-colony stimulating factor (G-CSF) induced regeneration of dopaminergic neurons and improved behavior deficit in moderate Parkinson's disease (PD) model mice. Post treatment of G-CSF in severe PD model has not been addressed. A very severe PD model in rats was induced by a high dose 6-hydroxydopamine (6-OHDA) injected into the right medial forebrain bundle to evaluate therapeutic effects of G-CSF. G-CSF (50 μg/kg/day for five days) was given on the 9th day after the 6-OHDA injection. Rotational behavior was examined on the 9th and 28th days. Rats were killed on the 28th day and survival dopaminergic neurons in the substantia nigra, dopaminergic axons and dopaminergic receptor 2 in the striatum were examined. We, for the first time, demonstrated that post treatment with G-CSF reduced abnormal rotational behavior and increased the lesion to non-lesion ratio of dopaminergic fibers in the striatum, but the treatment promoted neither the increase in survival dopaminergic neurons nor the increase in dopaminergic receptor 2 expression. We conclude that post treatment with G-CSF can reduce the abnormal rotational behavior of severe PD rats primarily through relative increases in dopaminergic fibers of the lesion side in the striatum. Results of our study suggest therapeutic potentials of G-CSF for treating severe PD patients.

並列關鍵字

axon ； dopaminergic ； granulocyte-colony stimulating factor (G-CSF) ； Parkinson's disease ； post treatment ； rat ； striatum ； 6-OHDA

參考文獻

Cao, X.Q.,Arai, H.,Ren, Y.R.,Oizumi, H.,Zhang, N.,Seike, S.,Furuya, T.,Yasuda, T.,Mizuno, Y.,Mochizuki, H.(2006).Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/ Bax expression levels.J. Neurochem..99,861-867.

Carlsson, M.,Carlsson, A.(1990).Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease.Trends Neurosci.13,272-274+C1-C4+275-276.

Drago, J.,Padungchaichot, P.,Accili, D.,Fuchs, S.(1998).Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.Dev. Neurosci..20,188-203.

Grealish, S.,Xie, L.,Kelly, M.,Dowd, E.(2008).Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.Brain Res. Bull..77,312-319.

Huang, H.Y.,Lin, S.Z.,Kuo, J.S.,Chen, W.F.,Wang, M.J.(2007).G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.Neurobiol. Aging.28,1258-1269.